American Society of Hematology, 2025 (ASH)7 - 9 December 2025
Concizumab Efficacy in Patients With Hemophilia A/B Without Inhibitors from the Phase 3 explorer8 Study: A Post-hoc Sensitivity Analysis for the Intra-patient Comparison of Concizumab With Previous Prophylaxis
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.